Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
出版年份 2018 全文链接
标题
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 119, Issue 10, Pages 1208-1214
出版商
Springer Nature America, Inc
发表日期
2018-10-10
DOI
10.1038/s41416-018-0246-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
- (2017) Geny Piro et al. OncoImmunology
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Davendra P.S. Sohal et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Metastatic pancreatic cancer: Is there a light at the end of the tunnel?
- (2015) Vanja Vaccaro WORLD JOURNAL OF GASTROENTEROLOGY
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease
- (2014) Davide Melisi et al. CURRENT PHARMACEUTICAL DESIGN
- O126 EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD
- (2014) G. Giannelli et al. JOURNAL OF HEPATOLOGY
- TGF-β Activation and Function in Immunity
- (2013) Mark A. Travis et al. Annual Review of Immunology
- Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies
- (2013) K. Sideras et al. CANCER TREATMENT REVIEWS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
- (2013) Anna Tamburrino et al. Frontiers in Pharmacology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search